Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03996148 · ClinicalTrials.gov registry record · Phase 4
Time to Post-Anesthesia Neurological Evaluation With Three Different Anesthetic Techniques
A Phase 4 study, sponsored by The Cooper Health System.
- Completed
- Registry status
- Phase 4
- Development phase
- 21
- Enrollment target
NCT03996148: Completed Phase 4 study, sponsored by The Cooper Health System.
NCT03996148 is a Phase 4 study that has completed, run by The Cooper Health System. The registered enrollment target is 21 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03996148, a Phase 4 study, has completed, sponsored by The Cooper Health System.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 21 participants
- Enrollment target
Study Summary
The objective of this pilot study is to analyze the differences in time to first postoperative neurological examination (cranial nerve XII - tongue movement, movement of extremities) and intraoperative hemodynamic stability with three different general anesthetic techniques that are used for carotid endarterectomy. Carotid endarterectomy surgery removes the plaque and stenosis but has a 1-3% risk of periprocedural stroke or death. The ability to detect neurological abnormalities early after surgery is vital in this patient population to facilitate timely additional diagnostics or interventions if a potential stroke is detected. Anesthetic techniques that facilitate an earlier reliable neurological exam will thus greatly benefit this surgical patient population. The primary objective of this pilot study is to determine the time difference from end of surgery to first neurologic exam between three commonly used anesthetic methods for carotid endareterectomy.
Primary Outcome
Time to first neurological exam after emergence from general anesthesia
Interventions
- DRUG Remifentanil, Propofol, and Desflurane
- DRUG Remifentanil, Dexmedetomidine, and Desflurane
- DRUG Remifentanil and Desflurane
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2017-09-29 |
| Est. Completion | 2018-09-19 |
| Phase | Phase 4 |
What the finished NCT03996148 record still lists
NCT03996148 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 3 interventions - of which Remifentanil, Propofol, and Desflurane is the first listed.
NCT03996148 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03996148 about?
NCT03996148 is a clinical study titled "Time to Post-Anesthesia Neurological Evaluation With Three Different Anesthetic Techniques". The objective of this pilot study is to analyze the differences in time to first postoperative neurological examination (cranial nerve XII - tongue movement, movement of extremities) and intraoperative hemodynamic stability with three different general anesthetic techniques that are used for carotid...
What is the current status of trial NCT03996148?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 21 participants. The study started on 2017-09-29. Estimated completion is 2018-09-19.
What interventions are being tested in trial NCT03996148?
The interventions under investigation include: Remifentanil, Propofol, and Desflurane (DRUG), Remifentanil, Dexmedetomidine, and Desflurane (DRUG), Remifentanil and Desflurane (DRUG).
Who is sponsoring clinical trial NCT03996148?
This trial is sponsored by The Cooper Health System, which has 39 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03996148's enrollment target sits among peer trials
21 1742nd of 2000 higher than 248 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI